Burkina Faso vs Mali: Cause of death, by non-communicable diseases, ages 5-14
Burkina Faso
23.1%
in 2021
Mali
22.5%
in 2021
Burkina Faso rank
143rd
Mali rank
146th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Burkina Faso
- Mali
How they compare
Burkina Faso currently reports 23.1% against 22.5% in Mali, a difference of 0.6%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Mali ahead.
Burkina Faso ranks 143rd and Mali ranks 146th of 185 countries.
Across the 3 decades both report, Burkina Faso averaged higher in 1 and Mali in 2.
Head to head by decade
| Decade | Burkina Faso | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.6% | 15.8% | 1.2% | Mali |
| 2010s | 21.0% | 21.2% | 0.2% | Mali |
| 2020s | 23.0% | 22.7% | 0.3% | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Burkina Faso or Mali?
- Burkina Faso, at 23.1% against 22.5% in Mali as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Burkina Faso and Mali?
- 0.6%, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and Mali?
- 6 years are reported by both, from 2000 to 2021.
- How do Burkina Faso and Mali rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Burkina Faso ranks 143rd and Mali ranks 146th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.